CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer

GRACEcast Lung Cancer Video by cancerGRACE - H. Jack West, MD

Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.